My regularly scheduled column in Contract Pharma can be read on-line here.

This month, a discussion on MKT, what it is, and what it is not, and whether some companies are playing fast-and-loose with its application to side-step regulatory requirements and short-change their packaging of temperature-sensitive biopharmaceutical products.